Researcher
Natacha Herssens
Affiliations
- Clinical Trials Unit (Research unit)
Member
From15 Apr 2013 → Today
Projects
1 - 2 of 2
- Is screening for gonorrhea and chlamydia cost-effective in reducing the cumulative incidence of these infections in men who have sex with men taking HIV pre-exposure prophylaxis (PrEP): a randomized, multicenter controlled trialFrom1 Jul 2020 → Today
- Novel High-Dose Tuberculosis Retreatment Regimens: How to overcome resistance without creating more?From1 Oct 2018 → Today
Publications
1 - 10 of 10
- Health itinerary-related survival of children under-five with severe malaria or bloodstream infection, DR Congo(2023)
Authors: Bieke Tack, Daniel Vita, José Nketo, Naomie Wasolua, Nathalie Ndengila, Natacha Herssens, Emmanuel Ntangu, Grace Kasidiko, Gaëlle Nkoji-Tunda, Marie-France Ndedi Phoba, et al.
Pages: e0011156 - Qualitative plasma viral load determination as a tool for screening of viral reservoir size in PWH(2022)
Authors: Thessa Laeremans, Sigrid D'haese, Jonathan Aernout, Kurt Barbé, Pieter Pannus, Sofie Rutsaert, Ellen Vancutsem, Guido Vanham, Coca Necsoi, Ward De Spiegelaere, et al.
Pages: 1761-1768 - Finding the right balance between efficacy and tolerability for TB treatment: the search continues(2021)
Authors: A.K.J. Maug, M.A. Hossain, Mourad Gumusboga, Tom Decroo, Wim Mulders, Sofie Braet, Jozefien Buyze, D A Jiménez, Céline Schurmans, Natacha Herssens, et al.
Pages: 84-86 - Infection Manager System (IMS) as a new hemocytometry-based bacteremia detection tool: a diagnostic accuracy study in a malaria-endemic area of Burkina Faso(2021)
Authors: Annelies Post, Bérenger Kaboré, Joel Bognini, Salou Diallo, Palpouguini Lompo, Basile Kam, Natacha Herssens, Fred van Opzeeland, Christa E van der Gaast-de Jongh, Jeroen D Langereis, et al.
- Antibacterial mouthwash to prevent sexually transmitted infections in men who have sex with men taking HIV pre-exposure prophylaxis (PReGo): a randomised, placebo-controlled, crossover trial(2021)
Authors: Christophe Van Dijck, Achilleas Tsoumanis, Anke Rotsaert, Bea Vuylsteke, Dorien Van Den Bossche, Elke Paeleman, Irith De Baetselier, Isabel Brosius, Jolein Laumen, Jozefien Buyze, et al.
Pages: 657-667 - First-line tuberculosis treatment with double-dose rifampicin is well tolerated(2020)
Authors: A.K.J. Maug, M.A. Hossain, Mourad Gumusboga, Tom Decroo, Wim Mulders, Sofie Braet, Jozefien Buyze, Diana Arango, Céline Schurmans, Natacha Herssens, et al.
Pages: 499-505 - Rapid viral rebound after analytical treatment interruption in patients with very small HIV reservoir and minimal on-going viral transcription(2020)
Authors: Pieter Pannus, Sofie Rutsaert, Stéphane De Wit, Sabine D. Allard, Guido Vanham, Basiel Cole, Coca Nescoi, Joeri Aerts, Ward De Spiegelaere, Achilleas Tsoumanis, et al.
- The XN-30 hematology analyzer for rapid sensitive detection of malaria: a diagnostic accuracy study(2019)
Authors: Annelies Post, Bérenger Kaboré, Isaie J Reuling, Joel Bognini, Wouter van der Heijden, Salou Diallo, Palpouguini Lompo, Basile Kam, Natacha Herssens, Kjerstin Lanke, et al.
- Comparative immunogenicity and safety trial of 2 different schedules of single-visit intradermal rabies postexposure vaccination(2019)
Authors: Patrick Soentjens, Katrien De Koninck, Achilleas Tsoumanis, Natacha Herssens, Dorien Van Den Bossche, Sanne Terryn, Steven Van Gucht, Pierre Van Damme, Y Van Herrewege, Emmanuel Bottieau
Pages: 797-804 - Discriminatory capacity between HIV-1 and HIV-2 of the new rapid confirmation assay Geenius(2014)
Authors: Natacha Herssens, G. Beelaert, K. Fransen
Pages: 11-15